|
TMOD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.05879996279168E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.08900005363944E-09 |
| Normal-vs-Stage2 |
3.371800E-02 |
| Normal-vs-Stage3 |
3.83219999999795E-06 |
| Normal-vs-Stage4 |
2.381100E-03 |
| Stage1-vs-Stage2 |
7.296600E-01 |
| Stage1-vs-Stage3 |
9.065200E-01 |
| Stage1-vs-Stage4 |
4.508000E-01 |
| Stage2-vs-Stage3 |
7.226800E-01 |
| Stage2-vs-Stage4 |
4.202800E-01 |
| Stage3-vs-Stage4 |
3.634000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.70661312543552E-12 |
| Normal-vs-AfricanAmerican |
4.189700E-02 |
| Normal-vs-Asian |
4.003100E-04 |
| Caucasian-vs-AfricanAmerican |
5.371500E-02 |
| Caucasian-vs-Asian |
9.750200E-01 |
| AfricanAmerican-vs-Asian |
5.091200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.16000567327046E-13 |
| Normal-vs-Female |
1.345200E-01 |
| Male-vs-Female |
4.381900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.761800E-03 |
| Normal-vs-Extreme_Weight |
2.60913513017158E-12 |
| Normal-vs-Obese |
1.53030999999748E-05 |
| Normal-vs-Extreme_Obese |
2.950600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.185160E-01 |
| Normal_Weight-vs-Obese |
6.094400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.233200E-01 |
| Extreme_Weight-vs-Obese |
1.743400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.661800E-01 |
| Obese-vs-Extreme_Obese |
9.328400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.096600E-03 |
| Normal-vs-Age(41-60Yrs) |
4.31219999996735E-06 |
| Normal-vs-Age(61-80Yrs) |
1.19550003230273E-09 |
| Normal-vs-Age(81-100Yrs) |
3.74249964352202E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.442600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.949200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.915900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.042400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.923720E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.678200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.7178480860025E-12 |
| Normal-VS-Type2 PRCC |
1.06719999504179E-09 |
| Normal-VS-KIRP CIMP |
7.652000E-02 |
| Normal-VS-Unclassified PRCC |
1.409430E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.985800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.657800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.159600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.854800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.908300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.378400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.52019960456096E-10 |
| Normal-vs-N1 |
5.3443000003206E-07 |
| Normal-vs-N2 |
1.880360E-01 |
| N0-vs-N1 |
7.978400E-01 |
| N0-vs-N2 |
9.668000E-01 |
| N1-vs-N2 |
8.711000E-01 |
|
|
